Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Asset Writedowns and Impairment (2016 - 2025)

China Pharma Holdings filings provide 11 years of Asset Writedowns and Impairment readings, the most recent being -$27029.0 for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 94.1% to -$27029.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $213684.0, a 147.12% increase, with the full-year FY2025 number at -$1018.0, down 117.85% from a year prior.
  • Asset Writedowns and Impairment hit -$27029.0 in Q4 2025 for China Pharma Holdings, down from $25302.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $213379.0 in Q1 2025 to a low of -$458282.0 in Q4 2024.
  • Median Asset Writedowns and Impairment over the past 5 years was -$3212.0 (2022), compared with a mean of -$26725.9.
  • Biggest five-year swings in Asset Writedowns and Impairment: crashed 2924.19% in 2024 and later soared 10428.12% in 2025.
  • China Pharma Holdings' Asset Writedowns and Impairment stood at -$250622.0 in 2021, then surged by 95.96% to -$10136.0 in 2022, then surged by 260.09% to $16227.0 in 2023, then crashed by 2924.19% to -$458282.0 in 2024, then soared by 94.1% to -$27029.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were -$27029.0 (Q4 2025), $25302.0 (Q3 2025), and $2032.0 (Q2 2025) per Business Quant data.